8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor

Yazar: Budillon, A, Gennaro, E Di, Caraglia, M, Barbarulo, D, Abbruzzese, A, Tagliaferri, P
Baskı/Yayın Bilgisi 1999

Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibro...

Yazar: Budillon, A, Cereseto, A, Kondrashin, A, Nesterova, M, Merlo, G, Clair, T, Cho-Chung, Y S
Baskı/Yayın Bilgisi 1995

Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.

Yazar: Scala, S, Budillon, A, Zhan, Z, Cho-Chung, Y S, Jefferson, J, Tsokos, M, Bates, S E
Baskı/Yayın Bilgisi 1995

Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Yazar: Pinto, A, Aldinucci, D, Gattei, V, Zagonel, V, Tortora, G, Budillon, A, Cho-Chung, Y S
Baskı/Yayın Bilgisi 1992

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

Yazar: Milone, M R, Pucci, B, Bruzzese, F, Carbone, C, Piro, G, Costantini, S, Capone, F, Leone, A, Di Gennaro, E, Caraglia, M, Budillon, A
Baskı/Yayın Bilgisi 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

Yazar: Milone, M R, Pucci, B, Bruzzese, F, Carbone, C, Piro, G, Costantini, S, Capone, F, Leone, A, Di Gennaro, E, Caraglia, M, Budillon, A
Yayımlandı Cell Death Dis (2014)

Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II s...

Yazar: Avallone, A, Delrio, P, Guida, C, Tatangelo, F, Petrillo, A, Marone, P, Cascini, L G, Morrica, B, Lastoria, S, Parisi, V, Budillon, A, Comella, P
Baskı/Yayın Bilgisi 2006

The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells

Yazar: Colangelo, T, Polcaro, G, Ziccardi, P, Muccillo, L, Galgani, M, Pucci, B, Rita Milone, M, Budillon, A, Santopaolo, M, Mazzoccoli, G, Matarese, G, Sabatino, L, Colantuoni, V
Yayımlandı Cell Death Dis (2016)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase

Yazar: Di Gennaro, E, Piro, G, Chianese, M I, Franco, R, Cintio, A Di, Moccia, T, Luciano, A, de Ruggiero, I, Bruzzese, F, Avallone, A, Arra, C, Budillon, A
Baskı/Yayın Bilgisi 2010

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways

Yazar: Bruzzese, F, Pucci, B, Milone, M R, Ciardiello, C, Franco, R, Chianese, M I, Rocco, M, Di Gennaro, E, Leone, A, Luciano, A, Arra, C, Santini, D, Caraglia, M, Budillon, A
Baskı/Yayın Bilgisi 2013

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

Yazar: Colangelo, T, Polcaro, G, Ziccardi, P, Pucci, B, Muccillo, L, Galgani, M, Fucci, A, Milone, M R, Budillon, A, Santopaolo, M, Votino, C, Pancione, M, Piepoli, A, Mazzoccoli, G, Binaschi, M, Bigioni, M, Maggi, C A, Fassan, M, Laudanna, C, Matarese, G, Sabatino, L, Colantuoni, V
Yayımlandı Cell Death Dis (2016)